Is GSK preparing to launch migraine drugs? The company refused it
While there was a rumor about transfer of antihypertensive ‘Pritor’ license not long ago, people concerned to the industry made an anticipation that GSK soon will launch a pain killer, Panadol or Excedrin. The company, however, responded this has never been discussed.
According to the industry o...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
